Evidence map›Paper›PMID 27329730›Full record

ArticleScientific reports2016

Effects of local delivery of BMP2, zoledronate and their combination on bone microarchitecture, biomechanics and bone turnover in osteoporotic rabbits.

Da Jing, Xuguang Hao, Fang Xu, Jian Liu, Fei Xu, Erping Luo, Guolin Meng

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Rabbit as model for osteoporosis research.Journal of bone and mineral metabolism · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Da JingDepartment of Biomedical Engineering, Fourth Military Medical University, Xi'an, China.
Xuguang HaoDepartment of orthopaedics, the Fifth Hospital of Harbin, Harbin, China.
Fang XuDepartment of Pharmacy, Zhejiang University of Technology, Hangzhou, Zhejiang, China.
Jian LiuInstitute of Orthopaedics, Xijing hospital, Fourth Military Medical University, Xi'an, China.
Fei XuDepartment of Radiation Oncology, PLA 302 hospital, Beijing, China.
Erping LuoDepartment of Biomedical Engineering, Fourth Military Medical University, Xi'an, China.
Guolin MengInstitute of Orthopaedics, Xijing hospital, Fourth Military Medical University, Xi'an, China.
Air Force Medical University · CNZhejiang University of Technology · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hip fracture is one major clinical challenge associated with osteoporosis, resulting in heavy socioeconomic burdens and high mortality. Systemic therapies of anti-osteoporosis drugs are expensive, time-consuming and also evoke substantial side effects, which fails to provide early protection from fractures. Accumulating evidence demonstrates the high bioavailability and therapeutic efficacy of local drug delivery in accelerating facture healing and bone defect repair. This study aims at investigating the effects of local delivery of BMP2 and zoledronate (two promising anabolic/anti-catobolic reagents) encapsulated by fibrin sealants into femoral necks on regulating bone quality and remodeling in osteoporotic rabbits subjected to combined ovariectomy and glucocorticoid injection. We show that 6-week BMP2 delivery exhibited more prominent effect on mitigating trabecular bone microarchitecture deterioration and mechanical strength reduction of femoral necks than local zoledronate treatment. BMP2 plus zoledronate showed more significant improvement of bone microstructure, mechanical strength and bone formation rate at 12 weeks post injection than single BMP2 or zoledronate delivery via μCT, biomechanical, histomorphometric and serum biochemical analyses. This study enriches our knowledge for understanding the availability of local drug delivery for improving bone quantity and quality, which may lead to earlier, safer and more efficient protection from osteoporosis-induced fractures in clinics.

Indexed as

AnimalsBiomechanical PhenomenaBone DensityBone Density Conservation AgentsBone Morphogenetic Protein 2Bone RemodelingDiphosphonatesDisease Models, AnimalDrug Delivery SystemsFemaleFemur NeckFibrin Tissue AdhesiveImidazolesOsteoporosisOvariectomyRabbitsBMP2 protein, humanBone Density Conservation AgentsBone Morphogenetic Protein 2DiphosphonatesFibrin Tissue AdhesiveImidazolesRecombinant ProteinsZoledronic Acid

Identifiers

PMID27329730
PMCPMC4916507
OpenAlexW2467800812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.